Pharmacological versus micro vascular decompression approaches for the treatment of trigeminal neuralgia: Clinical outcomes and direct costs

Journal of Pain Research

Volumn 4, Issue , 2011, Pages 233-244

  Lemos, Laurinda ^a,b   Alegria, Carlos ^c   Oliveira, Joana ^c   Machado, Ana ^b   Oliveira, Pedro ^d   Almeida, Armando ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b Unit of Fafe   (Portugal)

^c HOSPITAL DE BRAGA   (Portugal)

^d UNIVERSITY OF MINHO   (Portugal)

Author keywords

Carbamazepine; Clinical outcomes; Direct costs; Gabapentin associated with ropivacaine; Microvascular decompression; Trigeminal neuralgia

Indexed keywords

CARBAMAZEPINE; GABAMOX; GABAPENTIN; ROPIVACAINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DISEASE SEVERITY; DIZZINESS; DRUG COST; DRUG DOSE INCREASE; DRUG EFFICACY; EVENING DOSAGE; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HOSPITAL COST; HUMAN; HYPESTHESIA; MAJOR CLINICAL STUDY; MALE; MICROVASCULAR DECOMPRESSION; MONOTHERAPY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PARESTHESIA; PATIENT SATISFACTION; PHARMACOLOGICAL BLOCKING; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; RATING SCALE; SENSORY DYSFUNCTION; SICKNESS IMPACT PROFILE; TREATMENT DURATION; TRIGEMINUS NEURALGIA;

EID: 84860597547     PISSN: 11787090     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Cheshire W P. Trigeminal neuralgia: for one nerve a multitude of treatments. Expert Rev Neurother. 2007;7:1565-1579.
2. Tölle T, Dukes E, Sadosky A. Patient burden of trigeminal neuralgia: results from a cross-sectional survey of health state impairment and treatment patterns in six European countries. Pain Pract. 2006;6:153-160.
3. Lemos L, Flores S, Oliveira P, Almeida A. Gabapentin supplemented with Ropivacaine block of trigger-points improves pain control and quality of life in Trigeminal Neuralgia patients when compared with gabapentin alone. Clin J Pain. 2008;24:64-75.
4. Marbach JJ, Lund P. Depression, anhedonia and anxiety in temporoman-dibular joint and other facial pain syndromes. Pain. 1981;11:73-84.
5. Katusic S, Williams DB, Beard CM, Bergstralh EJ, Kurland LT. Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984. Neuroepidemiology. 1991;10:276-281.
6. MacDonald BK, Cockerell OC, Sander J W, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain. 2000;123:665-676.
7. Headache Classifcation Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia. 2004;24(Suppl 1):S16-S149.
8. Cheshire WP. Trigeminal neuralgia: a guide to drug choice. CNS Drugs. 1997;7:98-110.
9. Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain. 2002;18:22-27.
10. Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbazepine (tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 1966;29:265-267.
11. Jorns T P, Zakrzewska JM. Evidence-based approach to the medical management of trigeminal neuralgia. Br J Neurosurg. 2007;21:253-261.
12. Cruccu G, Gronseth G, Alksne J, et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2008;15:1013-1028.
13. Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain. 1997;73:223-230.
14. Royal M, Wienecke G, Movva V, et al. Open label trial of ox carbam-azepine in neuropathic pain. Pain Med. 2001;2:151-250.
15. Lemos L, Fontes R, Flores S, Oliveira P, Almeida A. Effectiveness of the association between carbamazepine and peripheral analgesic block with ropivacaine for the treatment of trigeminal neuralgia. J Pain Res. 2010;3:201-212.
16. Solaro C, Messmer Uccelli M, Uccelli A, Leandri M, Mancardi GL. Low-dose gabapentin combined with either lamotrigine or carbam-azepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. Eur Neurol. 2000;44:45-48.
17. Cheshire W P. Can MRI distinguish injurious from innocuous trigeminal neurovascular contact? J Neurol Neurosurg Psychiatry. 2005;76:1470-1471.
18. Lang E, Naraghi R, Tanrikulu L, et al. Neurovascular relationship at the trigeminal root entry zone in persistent idiopathic facial pain: findings from MRI 3D visualization. J Neurol Neurosurg Psychiatry. 2005;76:1506-1509.
19. Pagni CA, Fariselli L, Zeme S. Trigeminal neuralgia. Non-invasive techniques versus microvascular decompression. It is really available any further improvement? Acta Neurochir Suppl. 2008;101: 27-33.
20. Cheshire W P. Trigeminal neuralgia: diagnosis and treatment. Curr Neurol Neurosci Rep. 2005;5:79-85.
21. Barker FG II, Jannetta PJ, Bissonette DJ, et al. The long-term outcome of microvascular decomplression for trigeminal neuralgia. N Engl J Med. 1996;334:1077-1083.
22. Lovely TJ, Jannetta PJ. Microvascular decompression for trigeminal neuralgia. Surgical technique and long-term results. Neurosurg Clin N Am. 1997;8:11-29.
23. Kanpolat Y, Savas A, Bekar A, Berk C. Percutaneous controlled radiof-requency trigeminal rhizotomy for the treatment of idiopathic trigeminal neuralgia: 25-year experience with 1,600 patients. Neurosurgery. 2001;48:524-532.
24. Fountas KN, Lee G P, Smith JR. Outcome of patients undergoing gamma knife stereotactic radiosurgery for medically refractory idiopathic trigeminal neuralgia: Medical College of Georgia's experience. Stereotact Funct Neurosurg. 2006;84:88-96.
25. Dhople AA, Adams JR, Maggio WW, Naqvi SA, Regine WF, Kwok Y. Long-term outcomes of Gamma Knife radiosurgery for classic trigeminal neuralgia: implications of treatment and critical review of the literature. J Neurosurg. 2009;111:351-358.
26. Knafo H, Kenny B, Mathieu D. Trigeminal neuralgia: outcomes after gamma knife radiosurgery. Can J Neurol Sci. 2009;36:78-82.
27. Régis J, Metellus P, Hayashi M, et al. Prospective controlled trial of gamma knife surgery for essential trigeminal neuralgia. J Neurosurg. 2006;104:913-924.
28. Kondziolka D, Zorro O, Lobato-Polo J, et al. Gamma knife stereotactic radiosurgery for idiopathic trigeminal neuralgia. J Neurosurg. 2010; 112:758-765.
29. Gorgulho A, De Salles AA, McArthur D, et al. Brainstem and trigeminal nerve changes after radio surgery for trigeminal pain. Surg Neurol. 2006;66:127-135.
30. Regis J, Arkha Y, Yomo S, et al. Radio surgery in trigeminal neuralgia: long-term results and influence of operative nuances. Neurochirurgie. 2009;55:213-222.
31. Massager N, Murata N, Tamura M, et al. Influence of nerve radiation dose in the incidence of trigeminal dysfunction after trigeminal neuralgia radiosurgery. Neurosurgery. 2007;60:681-687.
32. Pollock BE, Ecker RD. A prospective cost-effectiveness study of trigeminal neuralgia surgery. Clin J Pain. 2005;21:317-322.
33. Tarricone R, Aguzzi G, Musi F, Fariselli L, Casasco A. Cost- effectiveness analysis for trigeminal neuralgia: Cyberknife vs microvascular decompression. Neuropsychiatr Dis Treat. 2008;4:647-652.
34. Pérez C, Saldaña MT, Navarro A, Martínez S, Rejas J. Trigeminal neuralgia treated with pregabalin in family medicine settings: its effect on pain alleviation and cost reduction. J Clin Pharmacol. 2009;49: 582-590.
35. Navarro A, Saldana MT, Pérez C, Torrades S, Rajas J. A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings. BMC Neurol. 2001;11(1):7(2011).
36. Zakrzewska JM. Trigeminal, eye, and ear pain. In: Melzack R, Wall PD, editors. Handbook of Pain Management - a clinical companion to Wall and Melzack's Textbook of Pain. London: Churchill Livingstone; 2003:199-215.
37. Lonser RR, Apfelbaum. Neurovascular decompression in surgical disorders of cranial nerves V, VII, IX, and X. In: Schmidek HH, Roberts DW, editors. Schmidek and Sweet's Operative Neurosurgical Techniques: Indications, Methods, and Results, 5th ed, Vo l 2. Philadelphia: Saunders/ Elsevier; 2002:1531-1543.
38. Ahmad M, Goucke CR. Management strategies for the treatment of neuropathic pain in the elderly. Drugs Aging. 2002;19:929-945.
39. Breivik H. Local anesthetic blocks and epidurals In: McMahon SB, Koltzenburg M, editors. Melzack's Textbook of Pain, 5th ed. London: Elsevier-Churchill Livingstone; 2006:903-925.
40. Manchikanti L, Singh V, Trescot AM, Deer TR, Boswell M V. Guidelines for the Practice of Interventional Techniques. In: Boswell M V, Cole BE, editors. Weiner's Pain Management: a practical guide for clinicians, 7th ed. London: CRS Press; 2006:847-878.
41. Lorenzoni J, David P, Devriendt D, et al. Patterns of neurovascular compression in patients with classic trigeminal neuralgia: a high-resolution MRI-based study. Eur J Radiol. 2009;doi:10.1016/j. ejrad.2009.09.017.
42. Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in millimeters? Pain. 1997;72:95-97.
43. Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL. Defining the clinically important difference in pain outcome measures. Pain. 2000;88:287-294.
44. Finnerup NB, Sindrup SH, Bach F W, Johannesen IL, Jensen TS. Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain. 2002;96:375-383.
45. Salaff F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain. 2004;8:283-291.
46. Zigmond AS, Snaith R P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-370.
47. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. an updated literature review. J Psychosom Res. 2002;52:69-77.
48. Bergner M, Bobbitt RA, Carter WB, et al. The sickness impact profile: development and final revision of a health status measure. Med Care. 1981;19:787-805.
49. Turner JA, Romano JM. Psychological and psychosocial evaluation. In: Loeser JD, Butler SH, Chapman CR, Turk DC, editors. "Bonica's Management of Pain", 3rd ed. Philadelphia: Lippincott Williams & Williams; 2001:329-341.
50. Jamison RN. The role of psychological testing and diagnosis in patients with pain. In: Dworkin RH, Breitbart WS, editors. Psychological Aspects of Pain: a handbook for health care providers. Progress in Pain Research and Management, Vol 27. Seattle: IASP Press; 2004:117-137.
51. McIntyre T, Johnston M, Gouveia JL, et al. Resultados psicossociais na reabilitação pós enfarte do miocárdio em mulheres portuguesase escocesas. Project POCTI/ESP/35749/ 1999, from the Foundation for Science and Technology (Portugal). http://alfa.fct.mctes.pt/apoios/projectos/consulta/vglobal_projecto.phtml.en?idProjecto=35749&sapiens=1999. Accessed June 14, 2011.
52. Diário da República article 132/2008 (Portugal). Available at: http://www.dre.pt/. Accessed June 29, 2011.
53. Simposium Terapêutico 2008 (Portugal). Available at: http://www.simposium.pt/pagina_inicio. Accessed June 29, 2011.
54. Zakrzewska JM, Lopez BC. Trigeminal and glossopharyngeal neuralgia. In: McMahon SB, Koltzenburg M, editors. Melzack's Textbook of Pain, 5th ed. London: Elsevier-Churchill Livingstone; 2006: 1001-1010.
55. Canavero S, Bonicalzi V. Drug therapy of trigeminal neuralgia. Expert Rev Neurother. 2006;6:429-440.
56. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17:1113-1123.
57. Fujimaki T, Fukushima T, Miyazaki S. Percutaneous retrogasserian glycerol injection in the management of trigeminal neuralgia: long-term follow-up results. J Neurosurg. 1990;73:212-216.
58. Lee KH, Chang J W, Park YG, Chung SS. Microvascular decompression and percutaneous rhizotomy in trigeminal neuralgia. Stereotact Funct Neurosurg. 1997;68:196-199.
59. Apfelbaum RI. Neurovascular decompression: the procedure of choice? Clin Neurosurg. 2000;46:473-498.
60. Zakrzewska JM, Patsalos PN. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia. Pain. 2002;95:259-266.
61. Lefaucheur J P, Drouot X, Cunin P, et al. Motor cortex stimulation for the treatment of refractory peripheral neuropathic pain. Brain. 2009;132:1463-1471.
62. Castro AR, Siqueira SR, Perissinotti DM, Teixeira MJ, Siqueira JT. Emotional aspects of chronic orofacial pain and surgical treatment. Int J Surg. 2009;7:196-199.